Single-Cell Genome Sequencing Technology Market

Single-Cell Genome Sequencing Technology is a new technology to amplify and sequence the whole genome at the single cell level.
Single-Cell Genome Sequencing Technology Market contains market size and forecasts of Single-Cell Genome Sequencing Technology in Global, including the following market information:
Global Single-Cell Genome Sequencing Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Single-Cell Genome Sequencing Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NGS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Single-Cell Genome Sequencing Technology include Fludigim, QIAGEN, Illumina, F Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Bio-Rad, 10X Genomics, Inc., Oxford Nanopore Technologies and BGI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Single-Cell Genome Sequencing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single-Cell Genome Sequencing Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Single-Cell Genome Sequencing Technology Market Segment Percentages, by Type, 2021 (%)
NGS
PCR
qPCR
Microarray
MDA
Global Single-Cell Genome Sequencing Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Single-Cell Genome Sequencing Technology Market Segment Percentages, by Application, 2021 (%)
Academic and research laboratories
Biotechnology and biopharmaceutical companies
Clinics
Others
Global Single-Cell Genome Sequencing Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Single-Cell Genome Sequencing Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Single-Cell Genome Sequencing Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Single-Cell Genome Sequencing Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fludigim
QIAGEN
Illumina
F Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Bio-Rad
10X Genomics, Inc.
Oxford Nanopore Technologies
BGI
Pacific Biosciences
Tecan Group
Novogene Co. Ltd.
Takara Bio, Inc.